$4.84
+0.49 (+11.26%)
Open$4.36
Previous Close$4.35
Day High$5.18
Day Low$4.36
52W High$71.50
52W Low$3.92
Volume—
Avg Volume30.2K
Market Cap7.25M
P/E Ratio—
EPS$-21.93
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+94.2% upside
Current
$4.84
$4.84
Target
$9.40
$9.40
$5.45
$9.40 avg
$11.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.55M | 2.16M | 1.98M |
| Net Income | -75,914,697 | -609,365 | -497,914 |
| Profit Margin | -2,980.4% | -28.2% | -25.1% |
| EBITDA | -76,888,990 | -937,252 | -843,277 |
| Free Cash Flow | — | -606,690 | -515,846 |
| Rev Growth | +100.0% | +2.0% | +14.6% |
| Debt/Equity | — | 0.62 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |